Results 181 to 190 of about 9,828,326 (308)
GC B Cells, Tfh Cells, and Influenza bnAbs: Insights for Improving Universal Vaccine Design. [PDF]
Inoue T, Ise W, Kurosaki T.
europepmc +1 more source
This review elucidates how cancer cell metabolic reprogramming—across glucose, lipid, amino acid, and nucleotide pathways—remodels the tumor microenvironment to suppress anti‐tumor immunity and promote immune escape. Targeting these metabolic axes offers promising strategies to overcome immunotherapy resistance and enhance cancer treatment.
Guoqing Xiang +5 more
wiley +1 more source
SARS-CoV-2 Variants and Immune Evasion: Mapping the Future of Vaccine Design. [PDF]
Uzer F, Erendor F, Sanlioglu S.
europepmc +1 more source
Tumor‐associated inflammation retains antibody‐targeted or non‐specific antibody conjugated nanoparticles within the tumor microenvironment. Magnetic Particle Imaging (MPI) enables non‐invasive detection and differentiation of tumors from other organs, owing to higher nanoparticle retention by inflammatory cells in the tumor periphery.
Preethi Korangath +9 more
wiley +1 more source
mRNA vaccine design targeting Merkel cell polyomavirus for immunotherapy of Merkel cell carcinoma. [PDF]
Zubair A, Ahmad F, Shahani MY, Afghan N.
europepmc +1 more source
Temozolomide treatment activates GSK3β, driving DNMT1 phosphorylation, destabilization, and CD47 promoter hypomethylation in glioblastoma. This epigenetic shift upregulates CD47, enabling TMZ‐treated GBM cells to evade macrophage phagocytosis, survive chemotherapy, and acquire resistance.
Jie Li +11 more
wiley +1 more source
VaxLab: integrated platform for rapid multistrategy mRNA vaccine design. [PDF]
Kim J, Han Y, Kwon CY, Chang H.
europepmc +1 more source
Boronic acid‐based fluorescent hybrids have been used as part of a versatile platform for real‐time metabolic bioimaging across cellular and organismal scales. Including glucose‐responsive imaging in living cells and in an insulin‐deficient vertebrate model, this work opens new opportunities for the development of precision diagnostics, metabolic ...
Haobo Ge +13 more
wiley +1 more source
Cross-Protection in PRRSV: Mechanisms, Limitations, and Implications for Vaccine Design. [PDF]
Raev SA +5 more
europepmc +1 more source
CAR‐Engineered Cell Therapies Beyond Cancer: Reprogramming Fibrosis and Immune‐Mediated Inflammation
CAR‐engineered cell therapies are expanding beyond cancer toward immune resetting, pathological‐cell clearance, matrix remodeling, and microenvironmental reprogramming in autoimmune, inflammatory, and fibrotic diseases. This Review compares CAR‐T, CAR‐macrophage, and CAR‐NK platforms and proposes controllable spatiotemporal reprogramming to align ...
Peng Jun Xu +6 more
wiley +1 more source

